Evanguelos Xylinas obtained his medical degree at the University Paris Descartes and trained in urology at the Assistance Publique Hôpitaux de Paris. He held a 2-year fellowship in urologic oncology at Weill Cornell Medical College, New York Presbyterian Hospital, under supervision of Profs. Shahrokh Shariat and Douglas Scherr. He is currently an Associate Professor at the Department of Urology at Bichat Hospital, Paris Descartes University.
His main areas of scientific interest include outcomes and translational research in urothelial carcinoma of the upper and lower tract. He is the chairman of the EAU’s Young Academic Urologists Urothelial Carcinoma group, a board member of the EAU section of Onco-Urology (ESOU), and a member of the French Guidelines on Bladder Cancer. He is an active reviewer for several urological and oncological journals.
Marco Moschini received his medical degree in 2012 at Vita Salute-San Raffaele University- Milan, followed by his PhD in 2016 at Universita Magna Graecia. He attended a 1-year fellowship at the department of Urology of the Mayo Clinic in Rochester in 2015 and 1-year fellowship at the department of Urology of the General Hospital of Vienna. He is currently doing his residency in Urology in Luzern (Switzerland) since 2017.
Since 2017, Moschini has been an active member of the EAU’s Young Academic Urologists’ Urothelial Cancer Group. He is associate editor of Swiss Urology, and has been guest associate editor of an edition of Translational Andrology and Urology (TAU) based on non-muscle invasive bladder cancer. He is author of more than 100 peer-reviewed articles in international journals, more than 40 as first author. He serves as reviewer for more than 30 urological and oncological journals. His main interest regards urologic oncology with a focus on bladder, upper urinary tract and prostate cancers.
Benjamin Pradere received his medical degree in 2016 at François Rabelais University in Tours, France. He is currently MD in the Urology and Oncology Unit of the University Hospital Center of Tours. He attended a one-year clinical and research fellowship at the Urology department of Tenon Hospital Paris under the supervision of Prof. Traxer. He worked on conservative treatment of UTUC and on a new technology for urothelial carcinoma diagnosis which received several prizes, both nationally (French National Academy of Surgery) and internationally (AUA, Endourological society).
Since 2016, Pradere has been the chairman of the French Association of Young Urologists (AFUF), who create educational and scientific materials. He is involved in the EAU’s Young Urologists Office (YUO) and works closely with different associations of young urologists (YAU, ESRU, etc). Pradere is also involved as a Junior Associate for the EAU Guidelines since 2015 and has started to collaborate with the EAU Guidelines Office Social Media Group in 2018.
He authored and coauthored over 40 peer-reviewed articles in international journals, as well as several book chapters. He is involved as a reviewer in different national and international journals. His main areas of interest include urologic oncology and endo-urology with a focus on kidney, upper urinary tract and bladder cancers.
Francesco Soria received his medical degree in 2011 and trained in urology at the University of Turin. He attended a 6-month fellowship at the Medical University of Vienna urology department, under supervision of Prof. Shariat. He is currently consultant urologist at the same department. He will soon be appointed as consultant urologist and research assistant at the Department of Urology of the University of Turin.
His main areas of scientific interest regard urologic oncology, from translational research to medical and surgical therapy, with specific interest in non-muscle invasive bladder cancer. He is author of more than 60 peer-reviewed publications in international journals as well as of several book chapters. He is editor of the book How to treat urothelial cancer, edited by Springer and he currently serves as reviewer for more than 20 urological and oncological journals.